Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HX575 vs ERYPO for Anemia in Hemodialysis Patients
NCT00666835Phase 3Completed
- Sponsor
- Sandoz
- Start
- Apr 2004
- Primary completion
- Jan 2006
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 2
01
Overview
A Phase 3 trial of epoetin alfa in Anemia In Chronic Kidney Disease, sponsored by Sandoz. Started Apr 2004; status: completed.
02
Drugs
epoetin alfa
03
Conditions
Anemia In Chronic Kidney Disease
Beyond the preview
Go deeper on NCT00666835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666835.